Concepedia

Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses

Shanfeng Li, Peng Liang, Wei Zhao, Hua Zhong, Fuchun Zhang, Ziqiang Yan, Hong Cao

Vaccine · 2011 · 46 citations · 30 references

DOI

Concepts

References

30

Dengue/Dengue Hemorrhagic Fever: The Emergence of a Global Health Problem

Duane J. Gubler, Gary G. Clark · Emerging infectious diseases · 1995 · 664 citations · Full text

, , +14

Location and Characterization of the Antigenic Portion of the FMDV Immunizing Protein

Karl G. Strohmaier, R. Franze, K.‐H. Adam · Journal of General Virology · 1982 · 367 citations

, , +17

A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive.

Laila I. Muderspach, Sharon P. Wilczynski, Lynda D. Roman et al. · PubMed · 2000 · 311 citations

, , +17

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I–II trial

Willemien J. van Driel, Maaike E. Ressing, Gemma G. Kenter et al. · European Journal of Cancer · 1999 · 230 citations

, , +15

Dengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact Performance

Stephen J. Thomas, Ananda Nisalak, Kathryn B. Anderson et al. · American Journal of Tropical Medicine and Hygiene · 2009 · 225 citations

, , +13